Interleukin-35 Levels in Patients with Stable Coronary Artery Disease.
Ersan OflarMustafa Hakan SahinBulent DemirAbdulcelil Sait ErtugrulDidem Melis OztasMetin Onur BeyazMurat UgurlucanFatma Nihan Turhan CaglarPublished in: Arquivos brasileiros de cardiologia (2022)
It has been shown that IL-35 levels can be a new biomarker for stable CAD, and IL-35 is associated with the extension of CAD.